Veru Inc. is an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate cancer and breast cancer. The Veru prostate cancer pipeline includes VERU-111, VERU-100, and Zuclomiphene citrate. VERU-111 is an oral, first-in-class, new chemical entity that targets, crosslinks, and disrupts alpha and beta tubulin subunits of microtubules for the treatment of metastatic castration and androgen receptor resistant prostate cancer. VERU-100 is a novel, proprietary peptide formulation designed to address the current limitations of commercially available androgen deprivation therapies (ADT) for advanced prostate cancer. Zuclomiphene citrate is an oral nonsteroidal estrogen receptor agonist being developed to treat hot flashes, a common side effect caused by ADT in men with advanced prostate cancer. The Veru breast cancer pipeline includes enobosarm for AR+/ER+/HER2- metastatic breast cancer and VERU-111 for taxane resistant metastatic triple negative breast cancer. Enobosarm is an oral, first-in-class, new chemical entity, selective androgen receptor agonist that targets and activates the androgen receptor in AR+/ER+/HER2- metastatic breast cancer without unwanted masculinizing side effects. VERU-111 is also being advanced into a Phase 3 trial for the treatment of hospitalized patients with COVID-19 who are at high risk for acute respiratory distress syndrome.

Company profile
Ticker
VERU
Exchange
Website
CEO
Mitchell Steiner
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
FEMALE HEALTH CO
SEC CIK
Corporate docs
Subsidiaries
Aspen Park Pharmaceuticals, Inc. • Badger Acquisition Sub, Inc. • The Female Health Company Limited • The Female Health Company (UK) Plc. • The Female Health Company ...
IRS number
391144397
VERU stock data
News

Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
12 Aug 22
Nasdaq Turns Lower; Crude Oil Rises Sharply
11 Aug 22
Why Matterport Is Trading Higher By Around 25%, Here Are 73 Stocks Moving In Thursday's Mid-Day Session
11 Aug 22
Disney, Inotiv, Warby Parker And Some Other Big Stocks Moving Higher On Thursday
11 Aug 22
Dow Surges 200 Points; Six Flags Entertainment Shares Plummet
11 Aug 22
Press releases
Thinking about buying stock in Veru, CleanSpark, Moneylion, Vizio, or FuelCell Energy?
11 Aug 22
Veru Reports Third Quarter Fiscal 2022 Financial Results; Progresses Sabizabulin Treatment for COVID-19 Towards Regulatory Decisions in Key Territories
11 Aug 22
Veru to Report Fiscal 2022 Third Quarter Financial Results, Host Conference Call on August 11th
28 Jul 22
European Medicines Agency's Emergency Task Force Has Initiated the Review of Veru's Sabizabulin Treatment for Hospitalized COVID-19 Patients for Emergency Use in European Union Countries
27 Jul 22
UK's Medicines and Healthcare Products Regulatory Agency (MHRA) Supports Expedited Review of Marketing Authorization Application for Sabizabulin Treatment in Hospitalized COVID-19 Patients
25 Jul 22
Analyst ratings and price targets
Current price
Average target
$43.00
Low target
$31.00
High target
$55.00
Brookline Capital
Maintains
$31.00
Investment data
Securities sold
Number of investors
Calendar
11 Aug 22
12 Aug 22
30 Sep 22
Financial summary
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 21 | Sep 20 | Sep 19 | Sep 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Apr 22 | Steiner Mitchell Shuster | Common Stock Option Common Stock | Grant | Acquire A | No | No | 11.21 | 300,000 | 3.36M | 300,000 |
22 Apr 22 | Fisch Harry | Common Stock Option Common Stock | Grant | Acquire A | No | No | 11.21 | 200,000 | 2.24M | 200,000 |
22 Apr 22 | Michele Greco | Common Stock Option Common Stock | Grant | Acquire A | No | No | 11.21 | 100,000 | 1.12M | 100,000 |
22 Apr 22 | K Gary Barnette | Common Stock Option Common Stock | Grant | Acquire A | No | No | 11.21 | 200,000 | 2.24M | 200,000 |
29 Mar 22 | Grace Hyun | Common Stock Option Common Stock | Grant | Acquire A | No | No | 5.18 | 5,000 | 25.9K | 5,000 |
Institutional ownership, Q1 2022
28.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 102 |
Opened positions | 13 |
Closed positions | 24 |
Increased positions | 37 |
Reduced positions | 37 |
13F shares | Current |
---|---|
Total value | 110.25M |
Total shares | 22.71M |
Total puts | 367.9K |
Total calls | 684.25K |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
Perceptive Advisors | 4.36M | $21.07M |
BLK Blackrock | 4.11M | $19.87M |
Vanguard | 3.15M | $15.21M |
AWM Investment | 1.71M | $8.27M |
STT State Street | 1.16M | $5.62M |
Geode Capital Management | 1.13M | $5.48M |
Nuveen Asset Management | 754.58K | $3.83M |
NTRS Northern Trust | 587.68K | $2.84M |
Susquehanna International | 480.35K | $2.32M |
Citadel Advisors | 444.42K | $2.15M |
Financial report summary
?Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
European, expedited, faster, Force, franchise, Holdco, inducement, Journal, listing, Medicine, Member, microtubule, reserved, resumption, slowdown, Task, Union
Removed:
broad, calendar, daily, experiencing, grow, submit
Financial reports
Current reports
8-K
Results of Operations and Financial Condition
11 Aug 22
8-K
Veru Reports Second Quarter Fiscal 2022 Results and Progress of Sabizabulin for COVID-19 Toward a Request for Emergency Use Authorization
12 May 22
8-K
Departure of Directors or Certain Officers
31 Mar 22
8-K
Results of Operations and Financial Condition
9 Feb 22
8-K
Veru Reports Record Fiscal 2021 Full-Year Financial Results
2 Dec 21
8-K
Veru Sets Another Quarterly Record in Both Net Revenues
12 Aug 21
8-K
Departure of Directors or Certain Officers
14 May 21
8-K
Veru Reports Strong Second-Quarter Financial Results Based on Record High FC2 Prescription Revenues
12 May 21
8-K
Submission of Matters to a Vote of Security Holders
26 Mar 21
8-K
Veru Announces Proposed Public Offering of Common Stock
18 Feb 21
Registration and prospectus
S-8
Registration of securities for employees
11 Aug 22
S-8
Registration of securities for employees
12 May 22
424B5
Prospectus supplement for primary offering
18 Feb 21
424B5
Prospectus supplement for primary offering
17 Feb 21
424B5
Prospectus supplement for primary offering
13 Aug 20
POS AM
Prospectus update (post-effective amendment)
13 Aug 20
S-3
Shelf registration
26 Jun 20
424B5
Prospectus supplement for primary offering
26 Jun 20
S-8
Registration of securities for employees
13 May 20
S-8
Registration of securities for employees
15 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
28 Jan 22
DEFA14A
Additional proxy soliciting materials
28 Jan 21
DEFA14A
Additional proxy soliciting materials
11 Feb 20
DEFA14A
Additional proxy soliciting materials
28 Jan 20
DEFA14A
Additional proxy soliciting materials
28 Jan 19
DEF 14A
Definitive proxy
28 Jan 19
PRE 14A
Preliminary proxy
14 Dec 18
Other
EFFECT
Notice of effectiveness
17 Aug 20
EFFECT
Notice of effectiveness
2 Jul 20
CORRESP
Correspondence with SEC
29 Jun 20
UPLOAD
Letter from SEC
29 Jun 20
EFFECT
Notice of effectiveness
13 Nov 17
UPLOAD
Letter from SEC
4 Aug 16
CORRESP
Correspondence with SEC
17 Jul 16
UPLOAD
Letter from SEC
10 Jul 16
CORRESP
Correspondence with SEC
20 Jun 16
UPLOAD
Letter from SEC
13 Jun 16
Ownership
SC 13G
VERU / TANG CAPITAL PARTNERS ownership change
6 Jun 22
4
VERU / K GARY BARNETTE ownership change
25 Apr 22
4
VERU / Michele Greco ownership change
25 Apr 22
4
VERU / HARRY FISCH ownership change
25 Apr 22
4
VERU / MITCHELL SHUSTER STEINER ownership change
25 Apr 22
SC 13G
VERU / RA CAPITAL MANAGEMENT ownership change
21 Apr 22
4
VERU / Grace Hyun ownership change
31 Mar 22
SC 13G/A
VERU / VANGUARD ownership change
10 Feb 22
SC 13G
VERU / BlackRock ownership change
7 Feb 22
4
VERU / Mario Eisenberger ownership change
5 Nov 21
Patents
Utility
Methods of Treating Coronavirus
7 Oct 21
The present invention relates to methods of treating coronavirus infections using compounds having anti-tubulin or tubulin disruption activity.
Utility
COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTS
9 Sep 20
The invention provides compositions and methods for long term release of gonadotropin-releasing hormone (GnRH) antagonists and uses thereof.
Utility
Compounds for Treatment of Triple Negative Breast Cancer and Ovarian Cancer
25 Dec 19
The present invention encompasses methods of treating triple negative breast cancer and/or ovarian cancer using therapeutically effective amounts of compounds represented by the structure of formula I.
Transcripts
2022 Q3
Earnings call transcript
11 Aug 22
2022 Q2
Earnings call transcript
12 May 22
2022 Q1
Earnings call transcript
9 Feb 22
2021 Q4
Earnings call transcript
2 Dec 21
2021 Q3
Earnings call transcript
12 Aug 21
2021 Q2
Earnings call transcript
12 May 21
2021 Q1
Earnings call transcript
10 Feb 21
2020 Q4
Earnings call transcript
9 Dec 20
2020 Q3
Earnings call transcript
13 Aug 20
2020 Q2
Earnings call transcript
13 May 20
Reddit threads
(8/11) Thursday's Pre-Market Stock Movers & News
11 Aug 22
Daily Discussion Thread - August 11, 2022
11 Aug 22
Daily Discussion Thread for August 11, 2022
11 Aug 22
Daily Discussion Thread - August 11th, 2022
11 Aug 22
r/Stocks Daily Discussion & Options Trading Thursday - Aug 11, 2022
11 Aug 22
State of the sub
11 Aug 22
Funniest marketing campaign by a stock ever? VERU
10 Aug 22
I wanna play with some weeklies have $750 what's your plays
10 Aug 22
(8/10) Wednesday's Pre-Market Stock Movers & News
10 Aug 22
Daily Discussion Thread - August 10th, 2022
10 Aug 22